CytoDyn Inc.

CYDY

Exchange: OTC
Industry: Pharmaceutical Preparations
SEC CIK: 0001175680

SEC filings (opens in a new tab)

No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $35.2K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding CytoDyn Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of CYDY: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	16	18	+2
Shares	606.9K	610.3K	+3.35K (+0.6%)
Value	$1.21M	$568.8K	−$643.2K (−53.1%)

New holders (3)

Institutions that held CytoDyn Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CYDY in Q4 2021
Institution	Shares	Value	% of portfolio
Monograph Wealth Advisors, LLC	24,000	$24.0K	0.01%
United Community Bank	15,000	$14.8K	0.01%
Steward Financial Group LLC	500	$0	0.00%

Sold out (1)

Institutions that held CytoDyn Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of CYDY in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
MAI Capital Management	25,000	$50.0K